Critical Illness and Injury in Aging (R01) | Apply Online

Opportunity Summary:

The NIH funding opportunity announcement PA 10 042, titled "Critical Illness and Injury in Aging (R01)," supports research focused on understanding and improving how critical illness and serious injury affect older adults. The central aim is to encourage R01 Research Project Grant applications that examine both the underlying biological mechanisms and the practical clinical management of critical illness and injury in aging populations. The scope is broad and includes major medical and surgical critical illnesses as well as trauma and neurotrauma, reflecting the reality that older adults often experience different physiology, risks, and recovery trajectories compared to younger patients.

Projects can be designed in several complementary ways, depending on the key question being addressed. Applicants may propose mechanistic studies to identify biological pathways that drive vulnerability or poor outcomes in older adults, such as age-related changes in immune response, inflammation, coagulation, metabolism, muscle wasting, neurologic resilience, or organ reserve. Observational studies are also encouraged, including studies that characterize risk factors, trajectories, and outcomes in real-world populations of older patients experiencing critical illness, injury, or intensive care. Interventional studies can be proposed as well, meaning applicants may test strategies intended to prevent complications, improve acute management, or enhance recovery and long-term function after critical illness or injury. In addition, the FOA explicitly allows secondary analyses of existing datasets, which is often a strong and efficient approach in this area, especially when leveraging large observational cohorts, registries, or completed clinical trials to answer aging-specific questions without needing to build a new dataset from scratch.

The announcement also clarifies that animal studies are acceptable when human studies are not feasible, which is relevant for early mechanistic work or situations where experimental control is necessary. In practice, that can mean using animal models to explore age-related differences in response to sepsis, hemorrhage, traumatic brain injury, or prolonged mechanical ventilation, then using those findings to inform clinical hypotheses and future translational studies.

This opportunity uses the NIH R01 mechanism, which is the standard multi-year research project grant designed for mature, hypothesis-driven projects with a well-developed research plan. The FOA runs alongside several companion announcements that cover the same or very similar scientific scope but use different grant mechanisms suited to different stages of research. Specifically, NIH offered parallel opportunities under an R21 mechanism (PA 10 044) for more exploratory or developmental projects, an R03 mechanism (PA 10 043) for smaller, limited-scope studies, and an R34 mechanism (PA 10 045) oriented toward clinical trial planning. This structure is meant to give investigators multiple entry points depending on the readiness of the science, the amount of preliminary data available, and whether the next step is discovery, small pilot work, or formal trial planning.

Funding and award volume are not specified as fixed numbers in the provided text. Instead, the FOA states that awards are contingent on the availability of NIH funds and on the submission of a sufficient number of meritorious applications. In other words, proposals are evaluated competitively through NIH peer review, and the final number of awards depends on both scientific quality and the institute budgets supporting the program.

Eligibility is intentionally broad and includes many types of domestic and non-domestic organizations. Eligible applicants include federal, state, county, city, and special district governments; public and private institutions of higher education (including state-controlled institutions); nonprofits with or without 501(c)(3) status (other than higher education institutions); for-profit organizations (including small businesses and other for-profits); independent school districts; public housing authorities and Indian housing authorities; and a range of tribal governments and tribal organizations. The FOA also lists additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, faith-based and community-based organizations, U.S. territories or possessions, regional organizations, and foreign organizations (non-U.S. entities). This wide eligibility is consistent with NIH practice when the science could be advanced by academic centers, healthcare systems, community partners, industry, or international collaborators with relevant populations or data resources.

From an administrative standpoint, the opportunity is categorized as a discretionary grant under NIH, posted on December 1, 2009, with an original and current closing date of January 7, 2013, and an archive date of February 7, 2013. It carries no cost sharing or matching requirement. The program is associated with multiple CFDA numbers, reflecting the cross-cutting nature of the topic across nursing research, lung disease research, neuroscience and neurological disorders, and aging research (93.361, 93.838, 93.853, 93.866). For applicants who needed assistance accessing the full announcement or had technical issues, NIH provided contacts through the NIH Office of Extramural Research webmaster.

Overall, PA 10 042 is best understood as an NIH effort to stimulate rigorous, aging-focused research on why older adults experience critical illness and injury differently and how care can be improved across the full arc of illness, from acute management through recovery and longer-term outcomes. It welcomes a range of study designs, encourages efficient use of existing data when appropriate, allows animal work when necessary, and connects to companion mechanisms that support earlier-stage projects and clinical trial planning.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Critical Illness and Injury in Aging (R21)

Previous opportunity: Critical Illness and Injury in Aging (R03)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 10 042

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 10 042) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 10 042", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.